- ►inserm.fr [PDF] SC Cunnane, M Plourde, F Pifferi, M Bégin, C Féart, … - Progress in Lipid …, 2009 - Elsevier Cognitive decline in the elderly, particularly Alzheimer's disease (AD), is a major socio-economic
and healthcare concern. We review here the literature on one specific aspect of diet affecting
AD, that of the ω3 fatty acids, particularly the brain's principle ω3 fatty acid – ... Cited by 3 - Related articles - All 3 versions
D Powell - GERIATRIC MEDICINE-LONDON-, 2008 - oldagepsychiatry.co.uk “This is the third annual Medicine for Old Age Psychiatrists conference. I came up with the concept
for this meeting because I felt old age psychiatrists needed a way of keeping up to date with the
latest developments in medicine, and I thought it would be a good way of refreshing their ... Related articles - View as HTML - BL Direct - All 2 versions
AR Atti - diss.kib.ki.se This doctoral thesis investigates the effect of somatic disorders on dementia, Alzheimer's disease
(AD) and brain aging in late-life. The data for the studies are provided by the Kungsholmen Project
(Studies I and II) and the Faenza Project (Studies III and IV). The Kungsholmen Project is ... Related articles
KL Lanctôt, RD Rajaram, N Herrmann - Therapeutic Advances in …, 2009 - tan.sagepub.com Abstract: Available symptomatic therapies for the treatment of Alzheimer's disease (AD) have
been based on known neurotransmitter dysfunctions associated with the illness. The
second-generation cholinesterase inhibitors and the N-methyl D-aspartate receptor ... Related articles - All 8 versions